NWRN logo

Newron Pharmaceuticals Community

SWX:NWRN Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 17 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

NWRN logo
Newron Pharmaceuticals
HE
HedgeY
Community Contributor

Newron Pharmaceuticals (NWRN) – Binary CNS Bets with 3-to-1 Upside

1. Catalysts Evenamide (Schizophrenia Add-On Therapy): The key growth catalyst for Newron is Evenamide, a novel glutamate-modulating drug in Phase III development for treatment-resistant schizophrenia (TRS).
View narrative
CHF 17.00
FV
60.1% undervalued intrinsic discount
32.43%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
12 days ago author updated this narrative